The specialty control plasma market is on a strong growth trajectory, with an estimated valuation of USD 9.8 billion in 2023, projected to rise to USD 17.8 billion by 2033. This growth represents a compound annual growth rate (CAGR) of 6.2% during the forecast period.
The demand for specialty control plasma is being driven by several key factors:
- Advancements in Diagnostic Testing: Specialty control plasma is crucial in laboratory diagnostics and assays, particularly for testing in areas such as blood coagulation, immunology, and hematology. Its use in the calibration and validation of diagnostic equipment ensures accurate results, thus driving demand in clinical and research settings.
- Increased Awareness of Blood Disorders: Rising awareness of blood-related conditions such as hemophilia, blood clotting disorders, and immunodeficiencies has increased the need for high-quality control samples like specialty control plasma. It is essential for disease monitoring and drug efficacy testing, boosting its market presence.
- Regulatory Standards and Quality Control: Stringent regulatory standards in the healthcare and life sciences industries require rigorous quality control procedures, where specialty control plasma plays a critical role in ensuring the accuracy and reliability of test results across laboratories.
- Growth in Biopharmaceuticals and Personalized Medicine: The growing biopharmaceutical sector and the rise of personalized medicine are creating new testing needs, which specialty control plasma can address. This includes testing for monoclonal antibodies and other biologics, which require precise calibration and validation.
- Research and Development in Clinical Trials: Specialty control plasma is indispensable in the development of new drugs and vaccines. It is used in preclinical and clinical trials to ensure the validity of assay results, making it vital for the success of ongoing research efforts in the medical field.
- Technological Improvements in Plasma Collection and Processing: Innovations in plasma collection, processing, and storage have expanded the availability of specialty control plasma, making it more accessible and affordable for use in various laboratory applications.
- Increasing Adoption in Emerging Markets: As healthcare infrastructure in emerging markets improves, there is a growing adoption of advanced diagnostic tools, creating additional demand for specialty control plasma for laboratories and clinical applications in these regions.
These factors, along with the increasing need for precision medicine and improved diagnostic capabilities, continue to drive the demand for specialty control plasma in both clinical and research environments.
Increased Market Demand: Get In-Depth Analysis and Insights with Our Complete Report!
Key Manufacturers and Suppliers of Specialty Control Plasma:
- Precision BioLogic Incorporated
- Baxter BioScience
- Grifols S.A.
- Shire Plc.
- VitroPharma
- Kedrion S.p.A.
- China Biologic Products (Shandong Taibang)
- Biotest AG
- Sanquin
- Talecris Biotherapeutics
- SK Plasma Co.
- CSL Ltd.
- Octapharma AG
- Cerus Corp.
Key Segments:
By Type:
- Factor VIII Concentrate
- Factor IX Concentrate
- Immunoglobulins
- Others
By Application:
- Coagulation disorders
- Hemophilia
- Von Willebrand disease
- Other clotting disorders
- Immunodeficiency diseases
- Hypogammaglobulinemia
By End User:
- Hospitals
- Diagnostic Laboratories
- Clinics
- Others
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- China
- Japan
- South Korea
- Middle East and Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
